Pharmacokinetic and Pharmacodynamic Study of CD 2027 3microg/g Oily Spray Applied Twice Daily for 3 Weeks Under Conditions of Maximized Use in Adults With Plaque-Type Psoriasis.
Phase of Trial: Phase II
Latest Information Update: 10 Jan 2012
At a glance
- Drugs Calcitriol (Primary)
- Indications Plaque psoriasis
- Focus Pharmacokinetics
- Sponsors Galderma
- 27 Oct 2009 New trial record.